Top 10 ASX Dividend Stocks for Nov 2026 Download Free Report
• Cleo Diagnostics Ltd is progressing development and commercial preparation for its ovarian cancer diagnostic technology.
• The company secured AUD 1.3mn for research related to its lung CT scanner program.
• The company has been implementing operational initiatives across its global analytical and life-science businesses.
• Avecho has recommenced recruitment for the second and final cohort of its pivotal Phase III insomnia trial.
Medibank is one of Australia's largest private health insurers, operating under the Medibank and ahm brands, and also provides health services through its Medibank Health division, which includes Amplar Health and general practice clinics.
Ramsay Health Care is a global hospital operator with businesses in Australia, the United Kingdom and Europe, including its Elysium mental health and neurological careBusinessand a majority stake in Ramsay Santé, its European operations.
According to the Appendix 4E lodged for the reporting period ended 30 June 2026, TrivarX reported revenues from ordinary activities of $14,566, compared with $1,128,979 in the previous corresponding period, a decrease of 98.71%. Total comprehensive loss attributable to members was $8,915,118, compared with …
Recently, the company reported total revenue and other income from continuing operations of $6.90 million in FY26, compared with $8.32 million in FY25, a decrease of $1.42 million. Revenue from contracts with customers was $6.08 million, down from $7.62 million in the prior year. …
Recently, the company reported EBITDA improving 85% year-on-year to -$922,000, with ordinary revenue from its three core verticals increasing 16.5% year-on-year to $16.8 million, up from $14.4 million in FY25. Total revenue for the period was $20.4 million, 3.1% ahead of the previous year, …
The Company noted that Australian dollar appreciation in H2 FY26 impacted reported earnings by approximately $5.0 million in revenue and $2.4 million in nEBITDA, as previously flagged in a May 2026 trading update. Excluding this foreign exchange impact in H2, revenue and nEBITDA were …
Please wait processing your request...
You are not subscribed for this report, Want to See?
One of our sales representative will contact you soon!
Welcome to Kalkine!
Start Your 7-Days Free Trial Today!
Hi! How can we help you today?
Loading…